<DOC>
	<DOC>NCT00162214</DOC>
	<brief_summary>The purpose of Segment 1 of the study is to determine the effect of ketoconazole on dasatinib. The purpose of Segment 2 is to learn how dasatinib affects tumor growth in patients with advanced solid tumors.</brief_summary>
	<brief_title>Study of Dasatinib in Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<mesh_term>Dasatinib</mesh_term>
	<criteria>ECOG status 02 Advanced or metastatic disease, unresponsive to standard treatment (or no standard treatment exists) Biopsy pretreatment Adequate bone marrow, liver and kidney function Serious cardiovascular disease Bleeding disorders Gastrointestinal (GI) tract disease Platelet inhibitors H2 blockers, proton pump inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Advanced Solid Tumors</keyword>
</DOC>